Evidence map›Paper›PMID 37000406›Full record

ReviewEndocrine2023

How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients.

Adnan Zaina, Nunzia Prencipe, Elena Golden, Alessandro Maria Berton, Eldad Arad, Ali Abid, Jeryes Shehadeh, Sameer Kassem, Ezio Ghigo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adnan ZainaDivision of Endocrinology and Metabolism, Clalit Medical Health Care Services, Tel Aviv, Haifa and Western Galilee District, Israel. zaina_adnan@yahoo.com.ORCID 0000-0001-7482-3104
Nunzia PrencipeEndocrinology, Diabetes and Metabolism, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy.
Elena GoldenDivision of Endocrinology and Metabolism, Clalit Medical Health Care Services, Tel Aviv, Haifa and Western Galilee District, Israel.
Alessandro Maria BertonEndocrinology, Diabetes and Metabolism, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy.
Eldad AradDivision of Endocrinology and Metabolism, Clalit Medical Health Care Services, Tel Aviv, Haifa and Western Galilee District, Israel.
Ali AbidDivision of Endocrinology and Metabolism, Clalit Medical Health Care Services, Tel Aviv, Haifa and Western Galilee District, Israel.
Jeryes ShehadehDivision of Cardiology, Zvulon Medical Center, Clalit Medical Health Care, Services, Tel Aviv, Haifa and Western Galilee District, Israel.
Sameer KassemDepartment of Internal Medicine, Carmel Medical Center, Haifa, Israel.
Ezio GhigoEndocrinology, Diabetes and Metabolism, Department of Medical Sciences, City of Health and Science University Hospital, University of Turin, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcromegalyDiabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsSymportersGlucoseHumansHypoglycemic AgentsSodiumGlucoseHypoglycemic AgentsSodiumSodium-Glucose Transporter 2 InhibitorsSymporters

Identifiers

PMID37000406

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.